<?xml version="1.0" encoding="UTF-8"?>
<item xmlns="http://omeka.org/schemas/omeka-xml/v5" itemId="4637" public="1" featured="0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="http://exhibits.library.stonybrook.edu/mfp/items/show/4637?output=omeka-xml" accessDate="2026-06-08T13:17:59+00:00">
  <fileContainer>
    <file fileId="5468">
      <src>http://exhibits.library.stonybrook.edu/mfp/files/original/5666f65a01324b7556aa0da8c8eee72a.pdf</src>
      <authentication>465dc4b9c905d77ba07b2334e8698efb</authentication>
      <elementSetContainer>
        <elementSet elementSetId="4">
          <name>PDF Text</name>
          <description/>
          <elementContainer>
            <element elementId="52">
              <name>Text</name>
              <description/>
              <elementTextContainer>
                <elementText elementTextId="106075">
                  <text>.w

‘1‘

mn my." ,,,, ... ..

October 7, 1970
Dr. Dorothy Dobbs
Food and Drug Administration
18733 Walker's Choice Rd.
Gaithersburg, Maryland 20760
Dear Dr. Dobbs:

to
writing to ask your advice as to the steps necessary
M 5050
new
narcotic
antagonist,
undertake human assays of a
I

am

—

diprenorphine.

Since 1965, we have been interested in treating opiate
a
dependence with narcotic antagonists. This therapy is based onwhich
and
Martin
Lexington,
Wikler
at
theoretic model, developed by
views opiate dependence as a psychological and physiological conditioning,

requiring

an active

extinction of conditioned responses for successful.

therapy. Following their lead,
as therapeutic agents.

we

have assayed cyclazocine and naloxone

short duration of action of both drugs has led us to seek
ways of extending their action, including the development of silastic
implants, in which duration is related to the rate of leaching into
the tissues and the amount of drug in the implant. Since amount of
drug and size of implant are directly related, we are seeking as
potent an antagonist as we can find for this purpose.
A

June 4 we convened a conference to review the available
by the
clinical and pharmacological data, and were heartened
developing
for
of
suggestions
clinical reports and by the variety
a long acting formulation.
On

V

discussant led us to M-SOSO, a narcotic compound produced
by Reckitt and Colman of Hull, England. In animal assays, it is a potent
has reported it to
antagonist without agonistic properties. Villareal
Colman
and
are preparing
Reckitt
naloxone.
be 16-20 times as potent as
narcotic M-99
with
a
potent
- very
to market this compound in a package
medicine.
to control large animals in veterinary
One

data, nor are they now interested in developing
the compound for human use. They are willing, however, to make supplies
available for our assay, both in animal pharmacology and clinical.
They have no human

�.,

.

‘w

--

r

“igummww .

-,

:9

mama- mum rum

wane-m1 :‘

"V‘mmfwf‘wﬁmmwrmv'ww

Dr. Dobbs

-

;“ nmmlr’lv‘wﬁww rummrwwww-w W‘r—wwizﬁ-Im»)"
w

|~

October 7, 1970

~2-

Our research program is supported by contracts from the New York
State Narcotic Addiction Control Commission, and we believe they will
support this project.

I am writing to ask your advice and assistance in formulating the
animal toxicology data prerequisite to our proposed clinical assays.
We would first determine if M 5050 is an antagonist to heroin, at
what dose, and for what duration after a single dose. If antagonism is
demonstrated, we would then define the oral or parenteral dose necessary
to produce continuous antagonism to heroin. (In this study we would
parallel the assays we have made of cyclazocine and naloxone.)
We

Enclosed are copies of all the data on M 5050 available to us.
also have an initial 10 granssupply for study.
What

additional data are necessary for us to file for single dose

assays in man?
we fol low?

What

toxicology data are needed?

What

procedures should

In addition to the M 5050 data, I am enclosing a summary of the
meeting as published in §gigngg; and reprints of our studies
of cyclazocine, naloxone and heroin, that will provide the background
for our interest in this program.

June

4

If useful, I
this request with
Many

would be pleased to visit your
you and your associates.

offices to discuss

thanks for your help.

Sincerely yours,
Max

Fink,

M.D.

Professor of Psychiatry

MF:kt

cc:

A. M. Freedman, 24.0.
H.

M.

Meiseles,
Luger ,

NACC
NACC

wuov'n - are "rm—Iva.

�</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </file>
  </fileContainer>
  <collection collectionId="1">
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1">
                <text>Correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </collection>
  <itemType itemTypeId="1">
    <name>Text</name>
    <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
  </itemType>
  <elementSetContainer>
    <elementSet elementSetId="1">
      <name>Dublin Core</name>
      <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
      <elementContainer>
        <element elementId="50">
          <name>Title</name>
          <description>A name given to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="46364">
              <text>Correspondence to: Dobbs, Dorothy</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="51">
          <name>Type</name>
          <description>The nature or genre of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="46365">
              <text>Text</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="43">
          <name>Identifier</name>
          <description>An unambiguous reference to the resource within a given context</description>
          <elementTextContainer>
            <elementText elementTextId="46366">
              <text>mfp-05-00-024-9-557</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="40">
          <name>Date</name>
          <description>A point or period of time associated with an event in the lifecycle of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="46367">
              <text>1970 </text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="39">
          <name>Creator</name>
          <description>An entity primarily responsible for making the resource</description>
          <elementTextContainer>
            <elementText elementTextId="46368">
              <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="49">
          <name>Subject</name>
          <description>The topic of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="46369">
              <text>Correspondence -- Correspondence</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="46">
          <name>Relation</name>
          <description>A related resource</description>
          <elementTextContainer>
            <elementText elementTextId="46370">
              <text>The Max Fink Collection</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="41">
          <name>Description</name>
          <description>An account of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="46371">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="47">
          <name>Rights</name>
          <description>Information about rights held in and over the resource</description>
          <elementTextContainer>
            <elementText elementTextId="46372">
              <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="48">
          <name>Source</name>
          <description>A related resource from which the described resource is derived</description>
          <elementTextContainer>
            <elementText elementTextId="46373">
              <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="44">
          <name>Language</name>
          <description>A language of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="78839">
              <text>en-US</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="42">
          <name>Format</name>
          <description>The file format, physical medium, or dimensions of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="85400">
              <text>application/pdf</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="45">
          <name>Publisher</name>
          <description>An entity responsible for making the resource available</description>
          <elementTextContainer>
            <elementText elementTextId="91961">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="37">
          <name>Contributor</name>
          <description>An entity responsible for making contributions to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="98522">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </elementSet>
  </elementSetContainer>
  <tagContainer>
    <tag tagId="4">
      <name>Correspondence</name>
    </tag>
  </tagContainer>
</item>
